McKesson Corp. closed 5.19% below its 52-week high of $637.51, which the company reached on August 2nd.

For the ninth year, CMS has named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based ...

We recently compiled a list of the Billionaire Larry Robbins’ Long-Term Stock Picks. In this article, we are going to take a ...

The latest trading session saw McKesson (MCK) ending at $602.95, denoting a -0.24% adjustment from its last day's close. The stock fell short of the S&P 500, which registered a gain of 0.92% for the ...

McKesson's stock appears undervalued, trading at 18 times forward earnings and free cash flow. See why MCK is a Hold.

Geneos Wealth Management Inc. increased its position in shares of McKesson Co. (NYSE:MCK – Free Report) by 5.6% in the 4th ...

The renewal for the ninth straight year includes McKesson's latest measure for resolution of health-related social needs.

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on McKesson (MCK – Research Report), with a ...

McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, ...

The West Virginia Supreme Court heard oral arguments Tuesday, Jan. 28, 2025, from attorneys for the city and county, as well ...

Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...

Shares of McKesson Co. (NYSE:MCK – Get Free Report) have been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are covering the firm, Marketbeat reports. Two investment ...